{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:16:19Z","timestamp":1790619379234,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-Nanchitou (Nan)-Ippan-009"],"award-info":[{"award-number":["H29-Nanchitou (Nan)-Ippan-009"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H29-Nanchitou (Nan)-Ippan-033"],"award-info":[{"award-number":["H29-Nanchitou (Nan)-Ippan-033"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["NEXT KAKENHI 25117001"],"award-info":[{"award-number":["NEXT KAKENHI 25117001"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["NEXT KAKENHI 25117012"],"award-info":[{"award-number":["NEXT KAKENHI 25117012"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1251-0","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T08:48:27Z","timestamp":1534150107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson\u2019s disease animal model"],"prefix":"10.1186","volume":"15","author":[{"given":"Atsushi","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jnc.13684","volume":"139","author":"I Morales","year":"2016","unstructured":"Morales I, Sanchez A, Rodriguez-Sabate C, Rodriguez M. The astrocytic response to the dopaminergic denervation of the striatum. J Neurochem. 2016;139:81\u201395.","journal-title":"J Neurochem"},{"key":"1251_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7\u201335.","journal-title":"Acta Neuropathol"},{"key":"1251_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/physrev.00041.2013","volume":"94","author":"M Pekny","year":"2014","unstructured":"Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94:1077\u201398.","journal-title":"Physiol Rev"},{"key":"1251_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2013.12.071","volume":"565","author":"M Pekny","year":"2014","unstructured":"Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte activation and reactive gliosis. Neurosci Lett. 2014;565:30\u20138.","journal-title":"Neurosci Lett"},{"key":"1251_CR6","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391\u2013410.","journal-title":"J Neurosci"},{"key":"1251_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"1251_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol. 2007;114:231\u201341.","journal-title":"Acta Neuropathol"},{"key":"1251_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4161\/oxim.3.4.12809","volume":"3","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Kim C, Lee SJ. Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxidative Med Cell Longev. 2010;3:283\u20137.","journal-title":"Oxidative Med Cell Longev"},{"key":"1251_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.nbd.2015.03.003","volume":"85","author":"D Bruck","year":"2016","unstructured":"Bruck D, Wenning GK, Stefanova N, Fellner L. Glia and alpha-synuclein in neurodegeneration: a complex interaction. Neurobiol Dis. 2016;85:262\u201374.","journal-title":"Neurobiol Dis"},{"key":"1251_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1006\/exnr.2002.7877","volume":"174","author":"LA Cunningham","year":"2002","unstructured":"Cunningham LA, Su C. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson\u2019s disease. Exp Neurol. 2002;174:230\u201342.","journal-title":"Exp Neurol"},{"key":"1251_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/ALN.0b013e318286cf36","volume":"118","author":"V Degos","year":"2013","unstructured":"Degos V, Charpentier TL, Chhor V, Brissaud O, Lebon S, Schwendimann L, Bednareck N, Passemard S, Mantz J, Gressens P. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology. 2013;118:1123\u201332.","journal-title":"Anesthesiology"},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67:715\u201325.","journal-title":"Ann Neurol"},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnagi.2014.00258","volume":"6","author":"G Charron","year":"2014","unstructured":"Charron G, Doudnikoff E, Canron MH, Li Q, Vega C, Marais S, Baufreton J, Vital A, Oliet SH, Bezard E. Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology? Front Aging Neurosci. 2014;6:258.","journal-title":"Front Aging Neurosci"},{"key":"1251_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s12264-014-1476-6","volume":"30","author":"J Clasadonte","year":"2014","unstructured":"Clasadonte J, Haydon PG. Connexin 30 controls the extension of astrocytic processes into the synaptic cleft through an unconventional non-channel function. Neurosci Bull. 2014;30:1045\u20138.","journal-title":"Neurosci Bull"},{"key":"1251_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nn.3662","volume":"17","author":"U Pannasch","year":"2014","unstructured":"Pannasch U, Freche D, Dallerac G, Ghezali G, Escartin C, Ezan P, Cohen-Salmon M, Benchenane K, Abudara V, Dufour A, et al. Connexin 30 sets synaptic strength by controlling astroglial synapse invasion. Nat Neurosci. 2014;17:549\u201358.","journal-title":"Nat Neurosci"},{"key":"1251_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/hmg\/ddg001","volume":"12","author":"B Teubner","year":"2003","unstructured":"Teubner B. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet. 2003;12:13\u201321.","journal-title":"Hum Mol Genet"},{"key":"1251_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/glia.20698","volume":"56","author":"A Koulakoff","year":"2008","unstructured":"Koulakoff A, Ezan P, Giaume C. Neurons control the expression of connexin 30 and connexin 43 in mouse cortical astrocytes. Glia. 2008;56:1299\u2013311.","journal-title":"Glia"},{"key":"1251_CR19","doi-asserted-by":"publisher","first-page":"e0124657","DOI":"10.1371\/journal.pone.0124657","volume":"10","author":"Y Jin","year":"2015","unstructured":"Jin Y, Raviv N, Barnett A, Bambakidis NC, Filichia E, Luo Y. The shh signaling pathway is upregulated in multiple cell types in cortical ischemia and influences the outcome of stroke in an animal model. PLoS One. 2015;10:e0124657.","journal-title":"PLoS One"},{"key":"1251_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2015.12.057","volume":"614","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yang B, Sun H, Zhou Y, Liu M, Ding J, Fang F, Fan Y, Hu G. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson\u2019s disease. Neurosci Lett. 2016;614:7\u201315.","journal-title":"Neurosci Lett"},{"key":"1251_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.expneurol.2005.11.004","volume":"199","author":"B Steiner","year":"2006","unstructured":"Steiner B, Winter C, Hosman K, Siebert E, Kempermann G, Petrus DS, Kupsch A. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson\u2019s disease. Exp Neurol. 2006;199:291\u2013300.","journal-title":"Exp Neurol"},{"key":"1251_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/NEN.0b013e3182269ecd","volume":"70","author":"T Yasuda","year":"2011","unstructured":"Yasuda T, Hayakawa H, Nihira T, Ren YR, Nakata Y, Nagai M, Hattori N, Miyake K, Takada M, Shimada T, et al. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2011;70:686\u201397.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1251_CR23","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1093\/brain\/aws254","volume":"135","author":"L Tonges","year":"2012","unstructured":"Tonges L, Frank T, Tatenhorst L, Saal KA, Koch JC, Szego EM, Bahr M, Weishaupt JH, Lingor P. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson\u2019s disease. Brain. 2012;135:3355\u201370.","journal-title":"Brain"},{"key":"1251_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2005.02.006","volume":"28","author":"M Theis","year":"2005","unstructured":"Theis M, Sohl G, Eiberger J, Willecke K. Emerging complexities in identity and function of glial connexins. Trends Neurosci. 2005;28:188\u201395.","journal-title":"Trends Neurosci"},{"key":"1251_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.neuropharm.2009.03.003","volume":"56","author":"C Viaggi","year":"2009","unstructured":"Viaggi C, Vaglini F, Pardini C, Caramelli A, Corsini GU. MPTP-induced model of Parkinson\u2019s disease in cytochrome P450 2E1 knockout mice. Neuropharmacology. 2009;56:1075\u201381.","journal-title":"Neuropharmacology"},{"key":"1251_CR26","doi-asserted-by":"crossref","unstructured":"Sedelis M, Schwarting RK, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res. 2001;125:109\u201325.","DOI":"10.1016\/S0166-4328(01)00309-6"},{"key":"1251_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0014-2999(86)90444-9","volume":"129","author":"PK Sonsalla","year":"1986","unstructured":"Sonsalla PK, Heikkila RE. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol. 1986;129:339\u201345.","journal-title":"Eur J Pharmacol"},{"key":"1251_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0361-9230(88)90240-7","volume":"21","author":"E Sundstrom","year":"1988","unstructured":"Sundstrom E, Luthman J, Goldstein M, Jonsson G. Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL\/6 mice. Brain Res Bull. 1988;21:257\u201363.","journal-title":"Brain Res Bull"},{"key":"1251_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-012-1509-2","volume":"374","author":"S Sayeed","year":"2013","unstructured":"Sayeed S, Asano E, Ito S, Ohno K, Hamaguchi M, Senga T. S100A10 is required for the organization of actin stress fibers and promotion of cell spreading. Mol Cell Biochem. 2013;374:105\u201311.","journal-title":"Mol Cell Biochem"},{"key":"1251_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2016.02.010","volume":"196","author":"SW Park","year":"2016","unstructured":"Park SW, Nhu le H, Cho HY, Seo MK, Lee CH, Ly NN, Choi CM, Lee BJ, Kim GM, Seol W, et al. p11 mediates the BDNF-protective effects in dendritic outgrowth and spine formation in B27-deprived primary hippocampal cells. J Affect Disord. 2016;196:1\u201310.","journal-title":"J Affect Disord"},{"key":"1251_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1750-3639.2004.tb00064.x","volume":"14","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Schwartz JP. Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. Brain Pathol. 2004;14:275\u201380.","journal-title":"Brain Pathol"},{"key":"1251_CR32","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","volume":"10","author":"J Yan","year":"2014","unstructured":"Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, Du G. Inflammatory response in Parkinson\u2019s disease (review). Mol Med Rep. 2014;10:2223\u201333.","journal-title":"Mol Med Rep"},{"key":"1251_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/neur.1996.0020","volume":"5","author":"A Czlonkowska","year":"1996","unstructured":"Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson\u2019s disease mice model. Neurodegeneration. 1996;5:137\u201343.","journal-title":"Neurodegeneration"},{"key":"1251_CR34","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","volume":"83","author":"A Kroner","year":"2014","unstructured":"Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel M, David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron. 2014;83:1098\u2013116.","journal-title":"Neuron"},{"key":"1251_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2012.06.045","volume":"1487","author":"M Theis","year":"2012","unstructured":"Theis M, Giaume C. Connexin-based intercellular communication and astrocyte heterogeneity. Brain Res. 2012;1487:88\u201398.","journal-title":"Brain Res"},{"key":"1251_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/cne.903020414","volume":"302","author":"T Yamamoto","year":"1990","unstructured":"Yamamoto T, Ochalski A, Hertzberg EL, Nagy JI. On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immunohistochemistry of connexin43 expression. J Comp Neurol. 1990;302:853\u201383.","journal-title":"J Comp Neurol"},{"key":"1251_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0306-4522(98)00191-2","volume":"88","author":"JI Nagy","year":"1999","unstructured":"Nagy JI, Patel D, Ochalski PA, Stelmack GL. Connexin30 in rodent, cat and human brain: selective expression in gray matter astrocytes, co-localization with connexin43 at gap junctions and late developmental appearance. Neuroscience. 1999;88:447\u201368.","journal-title":"Neuroscience"},{"key":"1251_CR38","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1164022","volume":"322","author":"N Rouach","year":"2008","unstructured":"Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science (New York, NY). 2008;322:1551\u20135.","journal-title":"Science (New York, NY)"},{"key":"1251_CR39","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.5665\/sleep.5824","volume":"39","author":"J Lu","year":"2016","unstructured":"Lu J, Chen M. Glial gap junctions boost modafinil action on arousal. Sleep. 2016;39:1175\u20137.","journal-title":"Sleep"},{"key":"1251_CR40","first-page":"19","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson\u2019s disease: an update. J Park Dis. 2011;1:19\u201333.","journal-title":"J Park Dis"},{"key":"1251_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tiv.2005.01.006","volume":"19","author":"MA Tirmenstein","year":"2005","unstructured":"Tirmenstein MA, Hu CX, Scicchitano MS, Narayanan PK, McFarland DC, Thomas HC, Schwartz LW. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicol in Vitro. 2005;19:471\u20139.","journal-title":"Toxicol in Vitro"},{"key":"1251_CR42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.febslet.2014.01.001","volume":"588","author":"JZ Zhou","year":"2014","unstructured":"Zhou JZ, Jiang JX. Gap junction and hemichannel-independent actions of connexins on cell and tissue functions\u2014an update. FEBS Lett. 2014;588:1186\u201392.","journal-title":"FEBS Lett"},{"key":"1251_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pbiomolbio.2007.03.009","volume":"94","author":"E Kardami","year":"2007","unstructured":"Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol. 2007;94:245\u201364.","journal-title":"Prog Biophys Mol Biol"},{"key":"1251_CR44","first-page":"3445","volume":"9","author":"F Fluri","year":"2015","unstructured":"Fluri F, Schuhmann MK, Kleinschnitz C. Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther. 2015;9:3445\u201354.","journal-title":"Drug Des Devel Ther"},{"key":"1251_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K. Axon degeneration in Parkinson\u2019s disease. Exp Neurol. 2013;246:72\u201383.","journal-title":"Exp Neurol"},{"key":"1251_CR46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3565(25)10739-8","volume":"262","author":"EY Wu","year":"1992","unstructured":"Wu EY, Langston JW, Di Monte DA. Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes. J Pharmacol Exp Ther. 1992;262:225\u201330.","journal-title":"J Pharmacol Exp Ther"},{"key":"1251_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuint.2003.09.007","volume":"45","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Schwartz JP. Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes. Neurochem Int. 2004;45:203\u201342.","journal-title":"Neurochem Int"},{"key":"1251_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nn.2136","volume":"11","author":"A Pascual","year":"2008","unstructured":"Pascual A, Hidalgo-Figueroa M, Piruat JI, Pintado CO, Gomez-Diaz R, Lopez-Barneo J. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci. 2008;11:755\u201361.","journal-title":"Nat Neurosci"},{"key":"1251_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tins.2008.11.006","volume":"32","author":"L Lin","year":"2009","unstructured":"Lin L, Lesnick TG, Maraganore DM, Isacson O. Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci. 2009;32:142\u20139.","journal-title":"Trends Neurosci"},{"key":"1251_CR50","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1006\/bbrc.1998.8986","volume":"248","author":"Y Mitsumoto","year":"1998","unstructured":"Mitsumoto Y, Watanabe A, Mori A, Koga N. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice. Biochem Biophys Res Commun. 1998;248:660\u20133.","journal-title":"Biochem Biophys Res Commun"},{"key":"1251_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.22383","volume":"70","author":"SR Kim","year":"2011","unstructured":"Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, During M, Kholodilov N, Burke RE. Dopaminergic pathway reconstruction by Akt\/Rheb-induced axon regeneration. Ann Neurol. 2011;70:110\u201320.","journal-title":"Ann Neurol"},{"key":"1251_CR52","doi-asserted-by":"publisher","first-page":"e32019","DOI":"10.1371\/journal.pone.0032019","volume":"7","author":"X Jing","year":"2012","unstructured":"Jing X, Miwa H, Sawada T, Nakanishi I, Kondo T, Miyajima M, Sakaguchi K. Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson\u2019s disease. PLoS One. 2012;7:e32019.","journal-title":"PLoS One"},{"key":"1251_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.mcn.2004.03.009","volume":"26","author":"BA Sieber","year":"2004","unstructured":"Sieber BA, Kuzmin A, Canals JM, Danielsson A, Paratcha G, Arenas E, Alberch J, Ogren SO, Ibanez CF. Disruption of EphA\/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine. Mol Cell Neurosci. 2004;26:418\u201328.","journal-title":"Mol Cell Neurosci"},{"key":"1251_CR54","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 2007;3:e98.","journal-title":"PLoS Genet"},{"key":"1251_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pneurobio.2017.12.003","volume":"162","author":"MK Jha","year":"2018","unstructured":"Jha MK, Kim JH, Song GJ, Lee WH, Lee IK, Lee HW, An SSA, Kim S, Suk K. Functional dissection of astrocyte-secreted proteins: implications in brain health and diseases. Prog Neurobiol. 2018;162:37\u201369.","journal-title":"Prog Neurobiol"},{"key":"1251_CR56","doi-asserted-by":"publisher","first-page":"40174","DOI":"10.1074\/jbc.M111.244038","volume":"286","author":"A Rezvanpour","year":"2011","unstructured":"Rezvanpour A, Santamaria-Kisiel L, Shaw GS. The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair. J Biol Chem. 2011;286:40174\u201383.","journal-title":"J Biol Chem"},{"key":"1251_CR57","first-page":"2263","volume":"17","author":"J Li","year":"2011","unstructured":"Li J, Riau AK, Setiawan M, Mehta JS, Ti SE, Tong L, Tan DT, Beuerman RW. S100A expression in normal corneal-limbal epithelial cells and ocular surface squamous cell carcinoma tissue. Mol Vis. 2011;17:2263\u201371.","journal-title":"Mol Vis"},{"key":"1251_CR58","first-page":"1858","volume":"11","author":"SY Hsu","year":"1997","unstructured":"Hsu SY, Kaipia A, Zhu L, Hsueh AJ. Interference of BAD (Bcl-xL\/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol Endocrinol. 1997;11:1858\u201367.","journal-title":"Mol Endocrinol"},{"key":"1251_CR59","doi-asserted-by":"crossref","unstructured":"Klomp LW, Gitlin JD. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet. 1996;5:1989\u201396.","DOI":"10.1093\/hmg\/5.12.1989"},{"key":"1251_CR60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.23817","volume":"73","author":"S Ayton","year":"2013","unstructured":"Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol. 2013;73:554\u20139.","journal-title":"Ann Neurol"},{"key":"1251_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov Disord. 2011;26:6\u201317.","journal-title":"Mov Disord"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1251-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T05:37:12Z","timestamp":1751780232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1251-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1251-0","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"6 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were carried out according to the guidelines for the proper conduct of animal experiments published by the Science Council of Japan, and ethical approval for the study was granted by the Animal Care and Use Committee of Kyushu University (#No. A29-179). The Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines for animal research were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RY has received research support from Bayer Schering Pharma, Biogen Japan, Novartis Pharma, and Mitsubishi Tanabe Pharma. JK is a consultant for Biogen Japan and has received honoraria from Bayer Healthcare, Mitsubishi Tanabe Pharma, Nobelpharma, and Otsuka Pharmaceutical. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"227"}}